Labcorp forecasts 2025 revenue above estimates on diagnostic test demand
Labcorp forecast 2025 revenue above Wall Street estimates after reporting fourth-quarter results beat on Thursday, banking on robust demand for its diagnostic tests.
Labcorp (LH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Beyond analysts' top -and-bottom-line estimates for Labcorp (LH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Labcorp Set to Report Q4 Earnings: What's in Store for the Stock?
In the fourth quarter of 2024, LH is likely to have witnessed strong growth in both diagnostics and biopharma laboratory services.
Labcorp (LH) Earnings Expected to Grow: Should You Buy?
Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Labcorp (LH) is Poised to Beat Earnings Estimates Again
Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Labcorp (LH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should You Retain Labcorp Stock in Your Portfolio Right Now?
Investors are increasingly optimistic about LH due to its focus on high-growth areas and strategic partnerships.
Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock
LH announces strategic agreement with Graves Gilbert Clinic for lab operations.
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain?
LH's new H5 bird flu test, developed in collaboration with the CDC, is now available in the United States.
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal
Labcorp is set to acquire select assets of MAWD Pathology Group.
Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand
For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth indicators through the growth of new locations and acquisitions, but also expected future patient demand for diagnostics. The company's main competitor/peer in this niche is Quest Diagnostics, and Labcorp struggles with a weak profit margin and growth in expenses.
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a government document sent to parliament showed.
